Media Summary: Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic Jared Weiss, MD, discusses the role of molecular In this segment, Lecia Sequist, MD, MPH, talks about guidelines for

Current Mutation Testing In Lung - Detailed Analysis & Overview

Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic Jared Weiss, MD, discusses the role of molecular In this segment, Lecia Sequist, MD, MPH, talks about guidelines for Keith Kerr, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, Scotland, discusses next generation ... The panelists, Benjamin Levy, MD; Paul K. Paik, MD; and Edward S. Kim, MD, FACP, explain the Biomarker Testing, Genomic Testing, Genetic

Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell In this video series that was recorded in July, September and November of 2025, leading oncologists Lynette M. Sholl, MD, and Geoffrey R. Oxnard, MD, discuss EGFR Sarah Goldberg, MD, describes the role of Dr. Sarah Goldberg from Yale Cancer Center talks about HER 2

Photo Gallery

Current Mutation Testing in Lung Cancer
Mutation Testing for Advanced Lung Cancer
Recommended Mutation Testing in Lung Cancer
Next generation sequencing in lung cancer
Mutation Testing and Lung-MAP
Biomarker Testing, Genomic Testing, Genetic Mutation Testing-Are They All the Same?
Mutation Testing in NSCLC
How do doctors test for genetic mutations in lung cancer and why is it important?
How to Test for HER-2 Mutations - Lung Cancer OncInsights 2025-26
Molecular Testing for EGFR Mutations: What Pathologists Need to Know
Mutation Testing in NSCLC
Mutation Testing for All Patients With NSCLC
View Detailed Profile
Current Mutation Testing in Lung Cancer

Current Mutation Testing in Lung Cancer

Roy S. Herbst, MD, PhD; Bruce E. Johnson, MD; and Mark A. Socinski, MD, discuss the role of genetic

Mutation Testing for Advanced Lung Cancer

Mutation Testing for Advanced Lung Cancer

Jared Weiss, MD, discusses the role of molecular

Recommended Mutation Testing in Lung Cancer

Recommended Mutation Testing in Lung Cancer

In this segment, Lecia Sequist, MD, MPH, talks about guidelines for

Next generation sequencing in lung cancer

Next generation sequencing in lung cancer

Keith Kerr, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, Scotland, discusses next generation ...

Mutation Testing and Lung-MAP

Mutation Testing and Lung-MAP

The panelists, Benjamin Levy, MD; Paul K. Paik, MD; and Edward S. Kim, MD, FACP, explain the

Biomarker Testing, Genomic Testing, Genetic Mutation Testing-Are They All the Same?

Biomarker Testing, Genomic Testing, Genetic Mutation Testing-Are They All the Same?

Biomarker Testing, Genomic Testing, Genetic

Mutation Testing in NSCLC

Mutation Testing in NSCLC

Luis Raez, MD, and Ben Levy, MD, discuss the role of next-generation sequencing for patients with non–small cell

How do doctors test for genetic mutations in lung cancer and why is it important?

How do doctors test for genetic mutations in lung cancer and why is it important?

Learn more about

How to Test for HER-2 Mutations - Lung Cancer OncInsights 2025-26

How to Test for HER-2 Mutations - Lung Cancer OncInsights 2025-26

In this video series that was recorded in July, September and November of 2025, leading oncologists

Molecular Testing for EGFR Mutations: What Pathologists Need to Know

Molecular Testing for EGFR Mutations: What Pathologists Need to Know

Lynette M. Sholl, MD, and Geoffrey R. Oxnard, MD, discuss EGFR

Mutation Testing in NSCLC

Mutation Testing in NSCLC

Sarah Goldberg, MD, describes the role of

Mutation Testing for All Patients With NSCLC

Mutation Testing for All Patients With NSCLC

The importance of

HER 2 Mutation Testing in Lung Cancer

HER 2 Mutation Testing in Lung Cancer

Dr. Sarah Goldberg from Yale Cancer Center talks about HER 2